Primary and Secondary Stroke Prevention in Children With Sickle Cell Disease

被引:9
|
作者
Kyle, A. [1 ]
Thompson, Alexis A. [1 ]
机构
[1] Northwestern Univ Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Pediat Hematol Oncol & Stem Cell Transplant, Chicago, IL USA
关键词
Cerebral infarct; sickle cell disease; stroke; transcranial Doppler ultrasonography; SILENT CEREBRAL INFARCTS; DOPPLER FLOW VELOCITIES; TRANSFUSION SIT TRIAL; TRANSCRANIAL DOPPLER; HYDROXYUREA; ANEMIA; THERAPY; RISK; ADULTS; BRAIN;
D O I
10.1016/j.pedhc.2016.06.005
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Children with sickle cell disease (SCD) have numerous acute and chronic complications, including central nervous system (CNS) disease, which can be debilitating over their life span. Recognition of risk factors for CNS disease and overt CNS disease should be properly identified by primary care providers, including physicians, physician assistants, and nurse practitioners. Here, we discuss an emerging and important early indicator of CNS disease in the form of silent cerebral infarcts and review overt stroke in patients with SCD. We also discuss transcranial Doppler ultrasonography, when and how often transcranial Doppler ultrasounds should be performed, and management of abnormal results. Lastly, we review the clinical data for the management and prevention of silent cerebral infarcts and overt stroke in children with SCD.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 50 条
  • [1] Barriers to primary stroke prevention in children with sickle cell disease
    Gardner, M
    Fullerton, HJ
    Adams, RJ
    Lo, LC
    Johnston, SC
    [J]. STROKE, 2006, 37 (02) : 744 - 745
  • [2] Obstacles to primary stroke prevention in children with sickle cell disease
    Fullerton, H. J.
    Gardner, M.
    Adams, R. J.
    Johnston, S. C.
    [J]. NEUROLOGY, 2006, 67 (06) : 1098 - 1099
  • [3] Sickle cell disease: Primary stroke prevention
    Gebreyohanns, M
    Adams, RJ
    [J]. CNS SPECTRUMS, 2004, 9 (06) : 445 - 449
  • [4] Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial
    Abdullahi, Shehu U.
    DeBaun, Michael R.
    Jordan, Lori C.
    Rodeghier, Mark
    Galadanci, Najibah A.
    [J]. PEDIATRIC NEUROLOGY, 2019, 95 : 73 - 78
  • [5] Utilization of TCD screening for primary stroke prevention in children with sickle cell disease
    Armstrong-Wells, J.
    Grimes, B.
    Sidney, S.
    Kronish, D.
    Shiboski, S. C.
    Adams, R. J.
    Fullerton, H. J.
    [J]. NEUROLOGY, 2009, 72 (15) : 1316 - 1321
  • [6] Hydroxyurea as secondary prevention for stroke in children with sickle cell anemia
    DeBaun, MR
    [J]. JOURNAL OF PEDIATRICS, 2005, 147 (04): : 560 - 561
  • [7] Treatment and prevention of stroke in children with sickle cell disease
    Mehta S.H.
    Adams R.J.
    [J]. Current Treatment Options in Neurology, 2006, 8 (6) : 503 - 512
  • [8] PROGRESSION OF CEREBRAL VASCULOPATHY IN CHILDREN WITH SICKLE CELL DISEASE UNDERGOING CHRONIC TRANSFUSION THERAPY FOR PRIMARY AND SECONDARY STROKE PREVENTION
    Cafiero, Rebecca
    Schlenz, Alyssa
    Kanter, Julie
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : 42 - 42
  • [9] Prospects for primary stroke prevention in children with sickle cell anaemia
    Jordan, Lori C.
    Casella, James F.
    DeBaun, Michael R.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (01) : 14 - 25
  • [10] Acceptability and Safety of Hydroxyurea for Primary Prevention of Stroke in Children with Sickle Cell Disease in Nigeria
    DeBaun, Michael R.
    Galadanci, Najibah Aliyu
    Abdullahi, Shehu U.
    Tabari, Musa A.
    Abubakar, Shehi
    Belonwu, Raymond
    Salihu, Auwal
    Neville, Kathleen A.
    Kirkham, Fenella J.
    Inusa, Baba P. D.
    Shyr, Yu
    Phillips, Sharon
    Kassim, Adetola A.
    Jordan, Lori C.
    Aliyu, Muktar H.
    Covert, Brittany V.
    [J]. BLOOD, 2014, 124 (21)